ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Development and reliability and validity testing of the Medication Literacy Scale for patients with chronic heart failure].
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesChronic heart failure (CHF) is characterized by high prevalence, high mortality, and high readmission rates. Optimized combination pharmacotherapy is the main approach to controlling clinical symptoms and reducing mortality and readmission rates. Ensuring medication safety is a top priority in disease management for patients with CHF, and adequate medication literacy is essential for medication safety. At present, there is a lack of disease-specific tools for assessing medication literacy in patients with CHF. This study aims to develop a Medication Literacy Scale for patients with CHF and to test its reliability and validity, thereby providing a reference for medication use in patients with CHF.
methodsAn initial item pool was established through literature analysis and group discussion. Items were optimized using qualitative methods, including Delphi expert consultation and cognitive interviews, and quantitative methods, including item analysis and exploratory factor analysis. Reliability was then evaluated using the Kuder-Richardson formula 20 (KR-20), split-half reliability, and test-retest reliability. Validity was assessed in terms of content validity, criterion-related validity, and construct validity.
resultsThe Medication Literacy Scale for patients with CHF consisted of 4 dimensions and 13 items, including 4 items for functional literacy and 3 items each for communicative literacy, critical literacy, and numeracy. A dichotomous scoring method was used, with a total score of 13; higher scores indicated higher levels of medication literacy among patients with CHF. The KR-20 coefficient of the total scale was 0.794, the split-half reliability was 0.701, and the test-retest reliability was 0.842. The item-level content validity index ranged from 0.90 to 1.00, the scale-level content validity index was 0.92, and the criterion-related validity coefficient was 0.739. The chi-square/degrees of freedom ratio was 1.472, the root mean square residual was 0.009, the root mean square error of approximation was 0.049, the goodness-of-fit index was 0.942, the adjusted goodness-of-fit index was 0.908, and both the comparative fit index and incremental fit index approached 0.9.
conclusionsThe Medication Literacy Scale for patients with CHF has a scientific theoretical basis, a standardized development process, and good reliability and validity. It can be used to assess medication literacy in patients with CHF. Clinical practitioners may use this scale to evaluate the overall level of medication literacy and the levels of each dimension among patients with CHF, thereby providing targeted medication guidance and ensuring medication safety in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.